Home › Funds › Western Standard LLC › INBX
Western Standard LLC position in INBX
INHIBRX BIOSCIENCES INC COM · Health Care
Western Standard LLC reported holding 47,000 shares of INBX (INHIBRX BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$4.5M, representing 1.51% of its reported portfolio and ranking #19 among its reported holdings. Western Standard LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Western Standard LLC's INBX position evolved
Western Standard LLC first disclosed a stake in INBX in Q2 2026 at 47,000 shares (US$4.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 47.00K | $4.45M | New |
About INBX and 13F data
INBX (INHIBRX BIOSCIENCES INC COM) is a Health Care company. 43 other funds we track also report a position in INBX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$123.0M), Sanofi (US$109.7M), Schonfeld Strategic Advisors LLC (US$66.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INBX
- PERCEPTIVE ADVISORS LLC 1.30M sh · $122.96M · Q2 2026
- Sanofi 1.16M sh · $109.71M · Q2 2026
- Schonfeld Strategic Advisors LLC 697.59K sh · $66.10M · Q2 2026
- PFM Health Sciences, LP 308.38K sh · $29.22M · Q2 2026
- Sofinnova Investments, Inc. 303.10K sh · $28.72M · Q2 2026
- Parkman Healthcare Partners LLC 256.95K sh · $24.35M · Q2 2026
- First Turn Management, LLC 164.78K sh · $15.61M · Q2 2026
More on Western Standard LLC
FAQ
How long has Western Standard LLC held INBX?
Western Standard LLC has disclosed INBX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Western Standard LLC's current position in INBX?
As of Q2 2026, Western Standard LLC holds 47.00K shares of INBX (INHIBRX BIOSCIENCES INC COM), valued at $4.45M, representing 1.51% of its reported portfolio and ranking #19.
Has Western Standard LLC been buying or selling INBX?
In the latest 13F filing (Q2 2026), Western Standard LLC newly opened its position in INBX.
Which other funds hold INBX?
Other major institutional holders of INBX include PERCEPTIVE ADVISORS LLC, Sanofi, Schonfeld Strategic Advisors LLC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.